Immunovant, Inc. Stock News

NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today an

Immunovant (IMVT) expects its lead pipeline candidate, batoclimab, being developed for treating several types of autoimmune diseases, to capture good market share, owing to its differentiated profile.

Immunovant (IMVT) expects its lead pipeline candidate, batoclimab, being developed for treating several types of autoimmune diseases, to capture good market share, owing to its differentiated profile.

Shares have lost roughly half their value since arriving on the Nasdaq in late 2019 via SPAC. Anti-FcRn space is increasingly attractive with 20+ indications on deck or being pursued by leaders Argenx

Shares of autoimmune disease focused biopharma company Immunovant Inc (US:IMVT) mounted an impressive sharp gain of 107% since the beginning of last week as a wave of news flow sparked a flash of inve

The drugmaker announced a $75 million public offering.

The drugmaker announced a $75 million public offering.

Gainers Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 104% to $2.9201. Shares of this low-float penny stock closed up about 80% on Tuesday. Crown ElectroKinetics Corp. (NASDAQ: CRKN) rose 91.2%

U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Wednesday. Here are some big stocks recording gains in today’s session. Nauticus Robotics, Inc. (NASDAQ: KITT) shares

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing more than 300 points on Tuesday. The Dow traded up 2.55% to 30,241.93 while the NASDAQ rose 3.14% to 11,155.04.

Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday. Connexa Sports Technologies Inc. (NASDAQ: CNXA) gained 96% to $0.57. CONNEXA recently announced a

U.S. stocks traded higher midway through trading, with the Nasdaq Composite climbing more than 250 points on Tuesday. The Dow traded up 2.45% to 30,050.95 while the NASDAQ rose 2.49% to 11,084.45. The

NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target. BigBea